826 filings
Page 3 of 42
6-K
KZIA
Kazia Therapeutics Limited
6 Jul 23
Current report (foreign)
4:15pm
6-K
KZIA
Kazia Therapeutics Limited
26 Jun 23
Kazia Corporate Update and Corporate Presentation
7:00am
6-K
KZIA
Kazia Therapeutics Limited
5 Jun 23
Kazia Expands Board of Directors with Appointment of Ebru Davidson
7:35am
6-K
KZIA
Kazia Therapeutics Limited
1 May 23
Kazia Announces Executive Leadership Changes
7:14am
6-K
KZIA
Kazia Therapeutics Limited
14 Apr 23
Current report (foreign)
7:49am
6-K
KZIA
Kazia Therapeutics Limited
4 Apr 23
Kazia Presents New Data for Paxalisib and EVT801
7:32am
6-K/A
KZIA
Kazia Therapeutics Limited
9 Mar 23
2. Results for announcement to the market
7:32am
6-K
KZIA
Kazia Therapeutics Limited
7 Mar 23
Kazia Therapeutics Announces Clinical Collaboration for Australian Phase Ii Precision Medicine Study of Paxalisib In Childhood Cancers
7:40am
6-K
KZIA
Kazia Therapeutics Limited
28 Feb 23
2. Results for announcement to the market
4:18pm
6-K
KZIA
Kazia Therapeutics Limited
24 Feb 23
Results of Egm
4:30pm
6-K
KZIA
Kazia Therapeutics Limited
24 Feb 23
Current report (foreign)
7:35am
6-K
KZIA
Kazia Therapeutics Limited
20 Jan 23
Current report (foreign)
7:59am
6-K
KZIA
Kazia Therapeutics Limited
17 Jan 23
Current report (foreign)
8:24am
6-K
KZIA
Kazia Therapeutics Limited
15 Dec 22
Kazia Launches Preclinical Collaboration with Qimr Berghofer Medical Research Institute and Announces Patent Filing
7:45am
6-K
KZIA
Kazia Therapeutics Limited
12 Dec 22
Kazia Announces Receipt of Nasdaq Minimum Bid Notification
4:01pm
6-K
KZIA
Kazia Therapeutics Limited
1 Dec 22
Current report (foreign)
4:13pm
6-K
KZIA
Kazia Therapeutics Limited
16 Nov 22
Current report (foreign)
9:27am
6-K
KZIA
Kazia Therapeutics Limited
16 Nov 22
Current report (foreign)
7:24am
6-K
KZIA
Kazia Therapeutics Limited
3 Nov 22
Current report (foreign)
7:30am
6-K
KZIA
Kazia Therapeutics Limited
27 Oct 22
Current report (foreign)
7:21am